Needham & Company Reiterates Buy on Medidata Solutions (MDSO) Following Strong 2Q Results
Needham & Company reiterated a Buy rating on Medidata Solutions (NASDAQ: MDSO), and raised the price target to $60.00 (from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
